Comparison of allograft to autograft in multilevelanterior cervical discectomy and fusion with rigid plate fixation☆
Introduction
Since initially reported in 1955 by Robinson and Smith [1], anterior cervical discectomy and fusion (ACDF) has become an accepted procedure for decompression of neural elements and spinal stabilization in the treatment of degenerative disease, trauma and tumors of the spine. Successful arthrodesis is instrumental in obtaining optimal outcome in ACDF. Selection of the appropriate graft substrate to optimize fusion rate and healing is essential. Various systemic factors, operative technique, plate type and work-related injuries are further components that can affect osseous fusion and clinical outcome.
Single-level ACDF is a highly successful procedure yielding high reported fusion rates, ranging from 83% to 97% and 82% to 94% for autograft [2], [3], [4], [5], [6] and allograft [2], [7], [8], respectively. However, in multilevel ACDF, as the number of grafts increases, the cervical spine is predisposed to decreased fusion rates as contact stress increases between the graft–body interface and further contributes to unacceptable micromotion [9]. Further, in multilevel ACDF, studies suggest that allograft is inferior to autograft in achieving arthrodesis. In 1991, in patients undergoing a two-level ACDF, Zdeblick and Ducker [10] noted nonunion in 63% of those with allograft and in 17% of those with autograft. Comparing the use of allograft plus demineralized bone matrix with autograft in patients with a two-level ACDF, An et al. [11] reported nonunion in 37.5% and 23.5% for allograft and autograft, respectively. Higher nonunion rates at 37% to 70% have been reported for three-level ACDFs [4], [11], [12], [13], [14].
Since the advent of an anterior cervical plating device [15], fusion rates for multilevel instrumented ACDF have increased [14], [16], [17], [18], [19]. Throughout the years, anterior cervical plating devices have evolved to increase internal stability, maintain alignment, facilitate fusion, decrease the incidence of graft extrusion and avoid postoperative halo bracing [20], [21], [22]. As previously discussed, single-level ACDF results in high fusion rates, but the addition of cervical plating may result in similar fusion rates and possibly worse clinical outcomes [23], [24]. Nonetheless, the use of anterior cervical plate fixation in multilevel ACDF is warranted to decrease high pseudarthrosis rates that accompany no internal fixation. A further consideration is that instrumentation failure remains a factor that could contribute to nonunion. Various studies have indicated the failure rate of anterior multilevel instrumentation is as high as 23% [25], [26].
The effectiveness of graft type in two-level ACDF with plate fixation is open to debate, largely because of inadequate allograft sample sizes [16], [18], [19], [24]. The graft efficacy for successful fusion in three-level ACDF with plate fixation is also questionable; previous literature has reported pseudarthrosis rates as high as 53% [27]. Although recent studies have demonstrated increased fusion rates with plate fixation for three-level ACDF, reports are few, and comparison of allograft to autograft in such patients has rarely been addressed [14], [17], [27], [28].
The selection of the appropriate graft substrate is imperative to achieve successful bone fusion and an optimal clinical outcome. However, there are multiple disadvantages associated with each graft type. The harvest site for autogenous iliac crest bone grafts is associated with an amplified risk of morbidity, operative time, hospital stay and postoperative recovery [29], [30], [31], [32], [33], [34]. Furthermore, patient dissatisfaction with the cosmetics of the iliac crest incision also contributes to the shortcomings of such a harvesting method [34]. Disadvantages are also associated with allograft and include histocompatibility differences that may affect proper healing, increased risk of infection, lack of availability and back ordering, size variations and possible structural weakness [10], [11], [35], [36], [37], [38], [39]. The use of allograft does avoid harvest site morbidity, is available in desired quantity, can be configured, decreases hospitalization time and reduces costs.
Although it is known that anterior plate fixation increases the fusion rate in multilevel ACDF patients, a debate still exists between the efficacy of allograft versus autograft and its relationship to clinical outcome in multilevel ACDF procedures. The purpose of this study is to address fusion rates, risk factors and clinical outcome in patients undergoing ACDF with rigid anterior plate fixation involving two or three levels with either allograft or autograft.
Section snippets
Materials and methods
Over a 7-year period, 80 consecutive patients who underwent two- or three-level ACDF with rigid anterior plate fixation were evaluated. There were 51 men and 29 women ranging in age from 28 to 78 years (mean age, 49 years), and two spine surgeons performed approximately an equal number of procedures. Indications for surgical intervention were progressive symptoms refractory to conservative treatment for radiculopathy, myelopathy or myeloradiculopathy resulting from degenerative spondylosis,
Results
All 80 patients were assessed for radiographic fusion (mean, 16 months; range, 9 to 79 months). Seventy-eight patients (97.5%) achieved successful bone fusion (94.3% allograft; 100% autograft). Fusion occurred in 60 of 61 (98.4%) two-level ACDFs and 18 of 19 (94.7%) three-level ACDFs (Fig. 1, Fig. 2). All nonunion cases were radiographically evaluated up to a minimum of 1 year. The loosening and migration of the inferior C7 screws in an ACDF allograft nonsmoker noted a fusion failure with Orion
Discussion
The literature has indicated that as the number of operative levels increases, the fusion rate decreases in nonplated ACDF [1], [14], [23], [35], [36], [41]. Anterior cervical plate fixation is believed to stabilize the operative motion segments, decreasing graft migration and preventing graft collapse that could lead to loss of cervical lordosis, malunion or nonunion and neurologic compromise. Although reports have noted high fusion rates in plated multilevel ACDF that range from 47% to 100%
References (62)
Anterior cervical fusion using Caspar plating: analysis of results and review of the literature
Surg Neurol
(1998)- et al.
Effects of nicotine on cellular function in UMR 106-01 osteoblast-like cells
Bone
(1991) - et al.
Anterolateral cervical disc removal and interbody fusion for cervical disc syndrome
Bull Johns Hopkins Hosp
(1955) - et al.
Anterior cervical interbody fusion using autogeneic and allogeneic bone graft substrate: a prospective comparative analysis
J Neurosurg
(1996) - et al.
The results of anterior interbody fusion of the cervical spine. Review of ninety-three consecutive cases
J Neurosurg
(1969) - et al.
The results of anterior interbody fusion of the cervical spine
J Bone Joint Surg [Am]
(1962) - et al.
Relief of pain by anterior cervical spine fusion for spondylosis. A report of sixty-five patients
J Bone Joint Surg [Am]
(1973) - et al.
Anterior cervical discectomy and fusion. A comparison of techniques in an animal model
Spine
(1992) - et al.
Bone allografts in spinal surgery
Clin Orthop
(1981) - et al.
Anterior cervical fusion using homologous bone grafts: a comparative study
Surg Neurol
(1976)
The role of distraction in improving the space available for the cord in cervical spondylosis
Spine
The use of freeze-dried allograft bone for anterior cervical fusions
Spine
Comparison between allograft plus demineralized bone matrix versus autograft in anterior cervical fusion. A prospective multicenter study
Spine
Outcome analysis of noninstrumented anterior cervical discectomy and interbody fusion in 348 patients
Spine
Three-level anterior cervical discectomy and fusion: radiographic and clinical results
Spine
Increased fusion rates with cervical plating for three-level anterior cervical discectomy and fusion
Spine
Anterior plate stabilization for fracture-dislocations of the lower cervical spine
J Trauma
Anterior cervical instrumentation enhances fusion rates in multilevel reconstruction in smokers
J Spinal Disord
Increased fusion rates with cervical plating for two-level anterior cervical discectomy and fusion
Spine
Cervical spondylosis: the role of anterior instrumentation after decompression and fusion
J Spinal Disord
Die ventrale interkorporale stabilisierung mit der HWS-Trapez-Osteosynthese-Platte: Indikation, Technik, Ergebnisse
Orthop Praxis
Die vordere verplattung der Halswirbelsaule mit dem Hohischerauben Platten System
Chirug
Osteossintese en los lesiones traumaticos y degenerativos de los coluvos cervoca
Rev Traumatol Cir Rehabil
Anterior cervical fusion: outcome analysis of patients fused with and without anterior cervical plates
J Spinal Disord
The significance of hardware failure in anterior cervical plate fixation. Patients with 2- to 7-year follow-up
Spine
Radiographic and clinical follow-up review of Caspar plates in 49 patients
J Neurosurg
Three- and four-level anterior cervical discectomy and fusion with plate fixation: a prospective study
Spine
Anterior cervical diskectomy and fusion without plate instrumentation in 178 patients
J Spinal Disord
Modified Smith-Robinson procedure for anterior cervical discectomy and fusion
Spine
Autologous bone grafting—complications at the donor site
J Bone Joint Surg [Br]
Cited by (170)
A Multicenter, Retrospective, Case Series of Patients With Charcot Neuroarthropathy Deformities Undergoing Arthrodesis Utilizing Recombinant Human Platelet-derived Growth Factor With Beta-Tricalcium Phosphate
2021, Journal of Foot and Ankle SurgeryCitation Excerpt :The 217 of 223 patient (97.31%) incidence of joint fusion and 13.09 ± 4.87 weeks (range 6-30 weeks) to fusion also fare well when compared to historical autograft controls (2). With respect to safety, we saw no complications specifically associated with the use of rhPDGF-BB/β-TCP, in contrast to potential complications seen with autograft or allograft (12-14). This suggests that the recombinant human platelet-derived growth factor is a safe and effective way to achieve high rates of fusion in a population with multiple high-risk factors for developing nonunions.
- ☆
FDA device/drug status: approved for this indication (anterior cervical plates).
Author HSA acknowledges a financial relationship (royalties from DePuy- Acromed for Peak Plate), which may indirectly relate to the subject of this research.